CPD  
 
   
 
 
Understanding the therapeutic uses of cannabinoids in pain and symptoms management
Back to conference list 
  Apr 23, 2009
Dr. Mark A. Ware MBBS MRCP(UK) MSc

Executive Director
Canadian Consortium for the Investigation of Cannabinoids

Assistant Professor, Anesthesia/Family Medicine
MUHC Pain Centre
McGill

Dr. Ware will be joining the forum. For section 1 accreditation you must interact on the forum.

Title:
Understanding the therapeutic uses of cannabinoids in pain and symptoms management
Description:
A discussion of the basic concepts of cannabinoid neurophysiology, the clinical trial evidence of cannabinoids in chronic disease management, the assess the risks and benefits of existing pharmaceutical cannabinoid preparations
and the attitudes towards the use of cannabis and cannabinoids in clinical practice.
Keywords:
pain, McGill, cannabinoids, marijuana, THC, Cannabidio, Nabilone, Anandamide, CB1, CB2
Category(ies):
Pain/Douleur; Anesthesia/Anesthesia; Pharmacology/Pharmacologie; CCIC; Inhalation Therapy/Inhalothérapie;
Accredited/Certified (1): Click here for details
You must login to view this conference
REGISTER NOW As New User
ACCESS As Returning User




, Montreal, QC, CA
Copyright © 2002-2017 Continuing Professional Development (CPD) Office,
Faculty of Medicine, McGill University